The potential association between a positive family history of breast cancer and the occurrence of lymphedema in a sample of ۳۰ patients treated at Fatemeh Zahra Hospital over a two-month period

Introduction: This study aimed to investigate the potential association between a positive family history of breast cancer and the occurrence of lymphedema in a sample of ۳۰ patients treated at Fatemeh Zahra Hospital over a two-month period. Lymphedema, characterized by the accumulation of fluid in the affected limb or area, is a common complication following breast cancer treatment. Methods: Patient records were collected and analyzed to determine the presence or absence of a positive family history of breast cancer and the occurrence of lymphedema. The data from the ۳۰ patients were examined to explore the relationship between family history and lymphedema development. Results: The findings provide valuable insights into the potential association between a positive family history of breast cancer and the occurrence of lymphedema. The analysis of the ۳۰ patients suggests that individuals with a family history of breast cancer may have a higher predisposition to develop lymphedema following breast cancer treatment. Understanding this relationship has important implications for identifying additional risk factors for lymphedema and enabling healthcare professionals to better assess the likelihood of its occurrence in patients with a positive family history. This knowledge can aid in developing personalized care plans and implementing preventive strategies to minimize the risk of lymphedema. Furthermore, recognizing the influence of genetic factors in lymphedema development can contribute to early detection and intervention. Patients with a positive family history may benefit from more frequent monitoring and tailored interventions to manage or prevent lymphedema. This can ultimately lead to improved patient outcomes and a better quality of life for breast cancer survivors. It is important to note that this study was conducted on a small sample size of ۳۰ patients over a two-month period at Fatemeh Zahra Hospital. Further research with a larger patient population is necessary to validate the findings and obtain more robust conclusions. Additionally, future studies could explore the underlying mechanisms or genetic markers that may contribute to the association between a positive family history of breast cancer and lymphedema. Conclusion: This study highlights the potential relationship between a positive family history of breast cancer and the occurrence of lymphedema in breast cancer patients. The findings underscore the importance of considering family history as a risk factor and integrating it into risk assessment and personalized care plans. By gaining a better understanding of this relationship, healthcare professionals can enhance preventive measures, early detection, and management strategies for lymphedema in breast cancer patients with a positive family history.

کلیدواژه ها:

Breast cancer ، Cancer ، Family history ، Lymphedema